Diagnosis of intrauterine fetal growth retardation (IUGR) and placental insufficiency by a dehydroepiandrosterone sulfate (DHAS) loading test
- PMID: 6226324
Diagnosis of intrauterine fetal growth retardation (IUGR) and placental insufficiency by a dehydroepiandrosterone sulfate (DHAS) loading test
Abstract
Chronic placental insufficiency results in intrauterine fetal growth retardation (IUGR). The IUGR can be diagnosed by clinical signs (follow-up of maternal weight, fundus height, abdominal circumference), ultrasound examination (biparietal and thoracic diameters, circumferences of the head and the trunk), and by endocrinologic tests (estrogen determination in serum and urine without and after performance of a DHAS loading test). The different ways of performing the DHAS loading test reported in the literature are reviewed. The DHAS loading test measures the aromatization capacity of the human placenta and indirectly its metabolic exchange capacities. After DHAS loading, estrogens (estrone, estradiol, estriol), DHAS and DHA can be determined in blood and urine; furthermore, changes in urine total estrogen excretion can be evaluated. In conclusion, the best parameter for diagnosing IUGR seems to be the determination of the DHAS half-life after DHAS loading. A prolongation of DHAS half-life (greater than 4.7 h) after DHAS loading (50 mg i.v.) is a good index of IUGR.
Similar articles
-
Diagnosis of intrauterine fetal growth retardation by prolongation of dehydroepiandrosterone sulfate (DHAS) half-life after DHAS loading.Eur J Obstet Gynecol Reprod Biol. 1982 May;13(3):145-58. doi: 10.1016/0028-2243(82)90025-9. Eur J Obstet Gynecol Reprod Biol. 1982. PMID: 6212274
-
Diagnosis of intrauterine fetal growth retardation by DHAS half-life.Eur J Obstet Gynecol Reprod Biol. 1986 Jun;22(1-2):41-51. doi: 10.1016/0028-2243(86)90088-2. Eur J Obstet Gynecol Reprod Biol. 1986. PMID: 2941326
-
[Study on the clinical evaluation of DHAS loading as a fetoplacental function test--effect of DHAS on estrogen metabolism at a fetoplacental unit].Nihon Sanka Fujinka Gakkai Zasshi. 1986 May;38(5):700-8. Nihon Sanka Fujinka Gakkai Zasshi. 1986. PMID: 2941503 Japanese.
-
[Endocrino-pharmacological study of reproduction: Role and biosynthesis of steroid hormones in the feto-placental unit].Nihon Yakurigaku Zasshi. 1981 Mar;77(3):231-44. Nihon Yakurigaku Zasshi. 1981. PMID: 6762983 Review. Japanese.
-
Placental-fetal interrelationship in IUGR fetuses--a review.Placenta. 2002 Apr;23 Suppl A:S136-41. doi: 10.1053/plac.2002.0802. Placenta. 2002. PMID: 11978072 Review.
Cited by
-
The organic anion transporter (OAT) family: a systems biology perspective.Physiol Rev. 2015 Jan;95(1):83-123. doi: 10.1152/physrev.00025.2013. Physiol Rev. 2015. PMID: 25540139 Free PMC article. Review.
-
Serum- and glucocorticoid-inducible kinase SGK2 regulates human organic anion transporters 4 via ubiquitin ligase Nedd4-2.Biochem Pharmacol. 2016 Feb 15;102:120-129. doi: 10.1016/j.bcp.2015.11.024. Epub 2015 Dec 29. Biochem Pharmacol. 2016. PMID: 26740304 Free PMC article.
-
Regulation of human organic anion transporter 4 by protein kinase C and NHERF-1: altering the endocytosis of the transporter.Pharm Res. 2010 Apr;27(4):589-96. doi: 10.1007/s11095-009-9983-2. Epub 2010 Feb 6. Pharm Res. 2010. PMID: 20140636 Free PMC article.
-
Regulation of human organic anion transporter 4 by parathyroid hormone-related protein and protein kinase A.Int J Biochem Mol Biol. 2012;3(3):322-7. Epub 2012 Sep 25. Int J Biochem Mol Biol. 2012. PMID: 23097748 Free PMC article.
-
The mechanistic links between insulin and human organic anion transporter 4.Int J Pharm. 2019 Jan 30;555:165-174. doi: 10.1016/j.ijpharm.2018.11.040. Epub 2018 Nov 16. Int J Pharm. 2019. PMID: 30453017 Free PMC article.